-
Product Insights
Tahoe Field, United States
Tahoe upstream field is located in Central Planning Area, United States. The upstream field is owned by MP Gulf of Mexico LLC (24%); W & T Energy Vi LLC (76%). It is operated by W & T Energy Vi LLC. The project started its operations in 1991. Tahoe Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including...
-
Product Insights
Kila Tahoe – Tahoe City Lodge Development – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Kila Tahoe - Tahoe City Lodge Development - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
Taho Inv – 401 Northeast URBN @ Flagler – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Taho Inv - 401 Northeast URBN @ Flagler - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Taho Inv – 421 Northeast URBN @ Flagler – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our Taho Inv - 421 Northeast URBN @ Flagler - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
JMA Ven – Tahoe Homewood Mountain Resort Redevelopment – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our JMA Ven - Tahoe Homewood Mountain Resort Redevelopment - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Judicial Council of California – New Tahoe Area Courthouse – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our Judicial Council of California - New Tahoe Area Courthouse - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Apixaban in Stroke
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Apixaban in Stroke Drug Details:Apixaban is under development for the treatment of stroke, deep vein thrombosis...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Apixaban in Pulmonary Embolism
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Apixaban in Pulmonary Embolism Drug Details:Apixaban is under development for the treatment of stroke, deep vein...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – GL-0034 in Obesity
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GL-0034 in Obesity Drug Details: GL-0034 is under development for the treatment of type...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MBK-001 in Non-Alcoholic Steatohepatitis (NASH)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.MBK-001 in Non-Alcoholic Steatohepatitis (NASH)Drug Details:MBK-001 is under development for the treatment of recurrent Clostridioides difficile...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Caficrestat in Cardiomyopathy
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Caficrestat in CardiomyopathyDrug Details:Caficrestat (AT-001) is under development for the treatment of diabetic complications including type...
-
Company Profile
![]()
Southwest Gas Corp – Company Profile
Southwest Gas Corp (Southwest) is a natural gas service company. It procures, distributes, and transports natural gas. The company sources natural gas from producing regions in Colorado and New Mexico (San Juan basin), Rocky Mountain areas and Texas (Permian basin). Southwest distributes, and transports natural gas to customers in portions of Arizona, Nevada, and California. Its service areas in Arizona including the central and southern areas of the state including Phoenix, Yuma, Tucson, and surrounding communities. In northern Nevada the...
Add to Basket -
Product Insights
Reno-Tahoe International Airport Expansion
Each construction project profile includes core details such as project name, stage, location, key dates, scope, background and description. Also included are key companies involved in the project such as project owner, planning authority, FEED/design company and main contractor, as well as selected operational metrics. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – pramipexole
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry pramipexole Drug Details Pramipexole is under development for the treatment of Parkinson's disease. It...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – TAH-8801
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry TAH-8801 Drug Details TAH-8801 is under development for the treatment of Alzheimer's disease. It...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – methylphenidate hydrochloride
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry methylphenidate hydrochloride Drug Details Methylphenidate hydrochloride (TAH-9901) is under development for the treatment of...
-
Product Insights
Schizophrenia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The symptoms of Schizophrenia include delusions, hallucinations, disorganized speech, and disorganized behavior. Risk factors include family history, age, drugs (psychoactive), and weakened immune system. Treatment includes antipsychotic medications. The Schizophrenia pipeline market research report provides comprehensive information on the therapeutics under development for Schizophrenia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development...
-
Product Insights
Parkinson’s Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Parkinson's disease (PD) is a neurodegenerative disorder characterized by movement dysfunctions. The main finding in brains of people with PD is loss of dopaminergic neurons in substantia nigra. Symptoms generally develop slowly over years. People with PD experience dyskinesia, dystonia, tremor, stiffness and impaired locomotory functions. Risk factors include age, genetic factors, environmental factors and gender. Treatment options include anticholinergics, COMT inhibitors and dopamine agonists. The Parkinson’s disease pipeline drugs market research report provides comprehensive information on the therapeutics under...
-
Product Insights
Transdermal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Transdermal drug delivery devices is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal drug delivery pipeline market research report provides comprehensive information about the transdermal drug delivery devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Attention Deficit Hyperactivity Disorder (ADHD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity, and impulsiveness. Symptoms of ADHD include disorganized work habits, procrastination, and inability to sustain attention on tasks or activities. Treatment includes analeptics. The ADHD Drugs in Development market research report provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) pipeline landscape. The report provides comprehensive information on the therapeutics under development for ADHD, complete with analysis by stage of development, drug target, mechanism of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.